ghk cu injections before and after GHK-Cu & After: Results & Timeline GHK-Cu Peptide for Body Composition

BPC-157 is not approved by the FDA

100% of participants on the 8 mg and 12 mg doses in Phase 2 achieved at least 5% weight loss

Instead, experimental evidence suggests that DSIP interacts indirectly with multiple receptor systems, including components of GABAergic, serotonergic, and opioid-associated pathways [1][2]

Lyophilized BPC-157 is generally documented as stable for up to 24 months when stored sealed at -20C, away from heat, light, and moisture

From the preclinical data for putative benefits there were also important side effects noted

Animal studies demonstrate that BPC-157 supports healing at these complex interface zones where different tissue types meet